Catarina Nascimento

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 10

Top Topics

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Tyrosine Kinase

Top Venues

Veterinary sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sofia Valente, Catarina Nascimento, Andreia Gameiro, João Ferreira, Jorge M J Correia, Fernando Ferreira
TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma. Cancers 15 (2) (2023)
Sofia Valente, Catarina Nascimento, Andreia Gameiro, João Ferreira, Jorge M J Correia, Fernando Ferreira
TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma. Cancers 15 (2) (2023)
Sofia Valente, Catarina Nascimento, Andreia Gameiro, João Ferreira, Jorge M J Correia, Fernando Ferreira
TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma. Cancers 15 (2) (2023)
Sofia Valente, Catarina Nascimento, Andreia Gameiro, João Ferreira, Jorge M J Correia, Fernando Ferreira
TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma. Cancers 15 (2) (2023)
Catarina Nascimento, Andreia Gameiro, Jorge M J Correia, João Ferreira, Fernando Ferreira
The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications. Cells 11 (16) (2022)
Andreia Gameiro, Filipe Almeida, Catarina Nascimento, Jorge M J Correia, Fernando Ferreira
Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma. Pharmaceutics 13 (3) (2021)
Maria Soares, Jorge M J Correia, Catarina Nascimento, Fernando Ferreira
Anaplastic Mammary Carcinoma in Cat. Veterinary sciences 8 (5) (2021)
Andreia Gameiro, Catarina Nascimento, Jorge M J Correia, Fernando Ferreira
HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models. Cancers 13 (9) (2021)
Andreia Gameiro, Catarina Nascimento, Jorge M J Correia, Fernando Ferreira
VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes. Cancers 13 (21) (2021)
Catarina Nascimento, Andreia Gameiro, João Ferreira, Jorge Correia, Fernando Ferreira
Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma. Cancers 13 (1) (2021)